Effects of Omeprazole and Eradication of Helicobacter pylori on Gastric and Duodenal Mucosal Enzyme Activities and DNA in Duodenal Ulcer Patients

References

• Vetvik K, Schrumpf E, Andersen K-J, Børkje B, Skagen D W., Halvorsen O J. Enzyme activities in the duodenal mucosa in duodenal ulcer patients. Scand J Gastroenterol 1989; 24: 244–50
   PubMed Web of Science ®Google Scholar
• Vetvik K, Schrumpf E, Andersen K-J, Berkje B, Odegaard S, Skagen D W., et al. Enzyme activities in the gastric mucosa in duodenal ulcer patients. Scand J Gastroenterol 1990; 25: 594–600
   PubMed Web of Science ®Google Scholar
• Vetvik K, Schrumpf E, Andersen K-J, Skagen D W., Halvorsen O J. Effect of ranitidine on gastric and duodenal mucosal enzyme activities in duodenal ulcer patients. Scand J Gastroenterol 1990; 25: 1123–8
   PubMed Web of Science ®Google Scholar
• Vetvik K, Schrumpf E, Andersen K-J, Skagen D W., Halvorsen O J. Effect of misoprostol and antacids on gastric and duodenal mucosal enzvme activities in duodenal ulcer patients. Scand J Gastroenterol 1991; 26: 385–91
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Lee A, Graham D Y., Dixon M F., Rokkas T. The role of infectious agents in peptic ulcer disease. Gastroenterol Im 1993; 6: 76–89
   Google Scholar
• Lauritsen K, Rutgersson K, Boiling E, Brunner G, Eriksson S, Frison L, et al. Omeprazole 20 or 40 mg daily for healing of duodenal ulcer? A double-blind comparative studv. Eur J Gastroenterol Hepatol 1992; 4: 995–1000
   Web of Science ®Google Scholar
• Børkje B, Ødegaard S, Skagen D W., Andersen K-J, Schrumpf E. Enzyme activities in biopsy specimens from human gastric mucosa. Scand J Gastroenterol 1986; 21: 1051–7
   PubMed Web of Science ®Google Scholar
• Smith P K., Krohn R I., Hermanson G T., Mallia A K., Gartner F H., Provenzano M D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76–85
   PubMed Web of Science ®Google Scholar
• Børkje B, Skagen D W., Andersen K-J, Schrumpf E. Longitudinal distribution of mucosal enzymes in the human large bowel. Scand J Gastroenterol 1986; 21: 919–27
   PubMed Web of Science ®Google Scholar
• Andersen K J., Schjonsby H, Skagen D W. Enzyme activities in human and rat jejunal mucosa. Scand J Gastroenterol 1983; 18: 241–9
   PubMed Web of Science ®Google Scholar
• Goodwin C S., Armstrong J A., Chilvers T, Peters M, Collins M D., Sly L, et al. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pvloricomb. nov. and Helicobacter mustelae comb. nov. respectively. Int J Syst Bact 1989; 39: 397–405
   Google Scholar
• Madsen J E., Vetvik K, Aase S. Helicobacter pylori and chronic active inflammation of the duodenum and stomach in duodenal ulcer patients treated with ranitidine, misoprostol, or an acid-neutralizing agent. Scand J Gastroenterol 1991; 26: 465–70
   PubMed Web of Science ®Google Scholar
• Kleinbaum D G., Kupper L L., Muller K E. Applied regression analysis and other multivariable methods. PWS-Kent Publishing Co., Boston 1998; 297–314
   Google Scholar
• Børkje B, Ødegaard S, Vetvik K, Skagen D W., Andersen K-J, Laerum O D. Influence of remote cancer and obesity on, and distribution of mucosal enzvmes in, the upper small intestine. Scand J Gastroenterol 1986; 21: 928–34
   PubMed Web of Science ®Google Scholar
• Naesdal J, Bodemar G, Walan A. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease. Scand J Gastroenterol 1984; 19: 916–22
   PubMed Web of Science ®Google Scholar
• Lanzon-Miller S, Pounder R E., Hamilton M R., Ball S, Chronos N AF, Raymond F, et al. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987; 1: 239–51
   PubMedGoogle Scholar
• Boyd E JS, Wilson J A., Wormsley K G. Recurrent ulcer disease. Ranitidine therapeutic advances, J J. Misiewicz, J R. Woods. Excerpta Medica, Amsterdam 1984; 14–42
   Google Scholar
• Ribet A, Balas D, Bastie M J., Senegas-Balas F, Escourrou J, Bommelaer G, . Long term effects of H:-receptor antagonists (cimetidine and ranitidine) on the human gastric and duodenal mucosa. Basic science in gastroenterology. Structure of the gut, J M. Polak, S R. Bloom, N A. Wright, M J. Daly, et al. Glaxo Group Research Limited, Ware, Herts. 1982; 157–76
   Google Scholar
• Lamers C BHW. The significance of gastrin in the pathogenesis and therapy of peptic ulcer disease. Drugs 1988; 35(Suppl 3)10–6
   PubMedGoogle Scholar
• Håkanson R, Sundler F. Trophic effects of gastrin. Scand J Gastroenterol 1991; 26(Suppl 180)130–6
   Web of Science ®Google Scholar
• Burlinson B, Morriss S, Gatehouse D G., Tweats D J., Jackson M R. Uptake of tritiated thymidine by cells of the rat gastric mucosa after exposure to loxitidine or omeprazole. Mutagenesis 1991; 6: 11–8
   PubMed Web of Science ®Google Scholar
• Phillips D H., Hewer A, Osborne M R. Interaction of omeprazole with DNA in rat tissues. Mutagenesis 1992; 7: 277–83
   PubMed Web of Science ®Google Scholar
• Hui W M., Lam S K., Ho J, Lai C L., Lok A SF, Lau W Y., et al. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci 1991; 36: 577–82
   PubMed Web of Science ®Google Scholar
• Day D W. Biopsy pathology of the oesophagus, stomach and duodenum. Biopsy pathology series. Chapman and Hall Medical, London 1986; 88–9
   Google Scholar
• Valentini M, Bortoluzzi F, Cernigoi C, Toffoli G, Bertolissi E, Cannizzaro R, et al. Effect of short- and long-term treatment with omeprazole on cell evele distribution in the gastric mucosa. Scand J Gastroenterol 1993; 28: 617–21
   PubMed Web of Science ®Google Scholar
• Goodwin C S., Armstrong J A. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis 1990; 9: 1–13
   PubMed Web of Science ®Google Scholar